William Blair Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform, 'Sets Up Second Half 2024 Approval and Launch'
Tweet Send to a Friend
(Updated - February 20, 2024 11:53 AM EST)
William Blair analyst Tim Lugo upgraded ARS Pharmaceuticals Inc (NASDAQ: SPRY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Tim Lugo upgraded ARS Pharmaceuticals Inc (NASDAQ: SPRY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
